Autus Asset Management LLC reduced its stake in shares of Clorox Company (The) (NYSE:CLX) by 6.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,537 shares of the company’s stock after selling 412 shares during the quarter. Autus Asset Management LLC’s holdings in Clorox Company (The) were worth $731,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Parkside Financial Bank & Trust lifted its stake in shares of Clorox Company (The) by 3.8% during the 2nd quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after purchasing an additional 29 shares during the last quarter. Valley National Advisers Inc. increased its position in Clorox Company (The) by 0.6% during the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares in the last quarter. Blue Chip Partners Inc. increased its position in Clorox Company (The) by 3.9% during the 2nd quarter. Blue Chip Partners Inc. now owns 941 shares of the company’s stock valued at $125,000 after buying an additional 35 shares in the last quarter. Sun Life Financial INC increased its position in Clorox Company (The) by 10,344.4% during the 2nd quarter. Sun Life Financial INC now owns 940 shares of the company’s stock valued at $125,000 after buying an additional 931 shares in the last quarter. Finally, Acrospire Investment Management LLC acquired a new position in Clorox Company (The) during the 2nd quarter valued at about $133,000. Hedge funds and other institutional investors own 72.74% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Autus Asset Management LLC Has $731,000 Position in Clorox Company (The) (CLX)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/21/autus-asset-management-llc-has-731000-position-in-clorox-company-the-clx.html.

Shares of Clorox Company (NYSE CLX) traded up $0.74 on Tuesday, hitting $135.33. The stock had a trading volume of 264,309 shares, compared to its average volume of 993,033. Clorox Company has a 1 year low of $112.28 and a 1 year high of $141.76. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02. The stock has a market capitalization of $17,450.00, a P/E ratio of 24.06, a price-to-earnings-growth ratio of 3.64 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last issued its earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The firm had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. The company’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.36 earnings per share. equities research analysts expect that Clorox Company will post 5.58 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a yield of 2.48%. Clorox Company (The)’s dividend payout ratio is currently 61.65%.

In other Clorox Company (The) news, SVP Matthew T. Laszlo sold 20,051 shares of the stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the transaction, the senior vice president now owns 10,896 shares in the company, valued at $1,421,492.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP James E. Foster sold 9,861 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total value of $1,365,847.11. Following the transaction, the executive vice president now owns 22,069 shares in the company, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. Insiders have sold 41,293 shares of company stock worth $5,560,303 in the last quarter. 1.00% of the stock is currently owned by company insiders.

Several research analysts recently issued reports on CLX shares. BMO Capital Markets set a $150.00 target price on Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Barclays PLC reaffirmed an “equal weight” rating and set a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Morgan Stanley reduced their target price on Clorox Company (The) from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 2nd. Zacks Investment Research lowered Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company’s stock. Clorox Company (The) has a consensus rating of “Hold” and an average target price of $128.72.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.